Agree, we should be working towards innovation partnerships and/or commercial partnerships with biotech. Maybe we are and are not being told just yet.
These 'liquids' that are being used now to test are ionised but I don't think are biomolecules. Need testing avenues with biotech companies.
Reading the Pitt Street overview of biochip plans, it is meant to disrupt mems sensors with graphene sensors. Mo had this line "people ask me , how do we stop sensors dissolving in liquids?" Well, the answer is, graphene does not dissolve and so is a major advantage/disruptor if they can integrate it with microfluidics.
The other key part of the current development phase we are in is packaging the sensors with the liquid channels. This, from my skim reading of papers is a problem yet to be solved effectively. No one has quite done it yet. Similar to the 12CQ, it's the ability to bring some new nanomaterials together with graphene into play that will overcome these tech barriers. Applying thin films to isolate and insulate.
AXE Price at posting:
30.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)